Geeta Mehta

15PUBLICATIONS
32CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyFunctional materialsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 15, 2026
Combination of oxidative phosphorylation and platelet-derived growth factor inhibitors for the treatment of ovarian cancers.

|Jun 30, 2025
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer (HGSC) cells, carcinoma associated fibroblasts, and macrophages.

Kathleen M Burkhard, Ayush Semwal, Benjamin K Johnson

|Nov 01, 2024
Ascitic Shear Stress Activates GPCRs and Downregulates Mucin 15 to Promote OvarianCancer Malignancy.

Geeta Mehta, Eric Horst, Liam Cotter

|Dec 14, 2023
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.

Akbar Hasanzadeh, Arefeh Ebadati, Lida Dastanpour

|May 14, 2022
Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers.

Arvinder Kapur, Pooja Mehta, Aaron D Simmons

|Aug 26, 2021
Design and applications of surfaces that control the accretion of matter.

Abhishek Dhyani, Jing Wang, Alex Kate Halvey

Pageof 3

Frequent Collaborators

3 joint publications

Shreya Raghavan

3 joint publications

Catherine S Snyder

3 joint publications

Anish Tuteja

1 joint publications

Vernon LaLone